Home  >  Products  >  ATP7A (ATPase, Cu++ transporting, alpha polypeptide (Menkes syndrome)) Blocking Peptide (100ug)
ATP7A (ATPase, Cu++ transporting, alpha polypeptide (Menkes syndrome)) Blocking Peptide (100ug)

ATP7A (ATPase, Cu++ transporting, alpha polypeptide (Menkes syndrome)) Blocking Peptide (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-ATP7A antibody (Catalogue #: ARP33797_T100) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP33797
Size: 100 ug
Weight: 30kDa
Gene: 538
Format: Lyophilized powder
Target: The ATP7A gene encodes the Menkes copper-translocating P-type ATPase, a ubiquitous protein that regulates the absorption of copper in the gastrointestinal tract. Inside cells, this protein has a dual function: it delivers copper to cuproenzymes in the Golgi compartment and effluxes excess copper. The trafficking mechanism and catalytic activity combine to facilitate absorption and intercellular transport of copper. Menkes disease, a systemic copper deficiency disorder, is caused by mutations in the ATP7A gene.
See Full Product Listings >